News on IVD Reagents and Diagnostics | Omini Dynamics

The Los Angeles event introduced the new scalp care product to U.S. buyers and opened discussions on brand partnerships and distribution.

Runda Rongjia BioTech showcased its ExoAion skincare and scalp care portfolio at Alibaba.com CoCreate 2026, held September 9–10 in Los Angeles. A highlight of the event was the launch presentation for ExoAion’s hop-derived exosome scalp care essence, extending the brand’s natural-origin vesicle technology into scalp and hair care.

According to the company’s event records, the team engaged with more than 500 prospective customers, over 100 of whom expressed interest in exploring commercial partnerships. Visitors included salon and spa owners, skincare product managers, aesthetic physicians and distributors, with discussions covering professional beauty, private-label development and distribution.

Introducing Hop Derived Vesicles for Scalp Care

The new ExoAion essence is the world’s first plant-derived exosome hair and scalp care product to reach mass production. It incorporates hop-derived vesicles in a leave-on scalp care format, expanding the portfolio beyond facial skincare and giving beauty brands and professional partners an additional product category to explore.

The launch also highlighted the company’s work on translating vesicle research into commercially manufactured products. Extraction, purification, stabilization and production scale-up are central to this development process, connecting ingredient research with finished-product applications.

What Buyers Discussed at the Booth

Conversations at the ExoAion booth focused on ingredient sourcing, the research behind the products and the ability to support ongoing supply. Plant-derived ingredients attracted interest from buyers exploring botanical approaches to skincare and scalp care, while formulation development and manufacturing capabilities were also part of the discussions.

For salon operators, brand teams and distributors, these conversations helped identify potential applications within existing beauty portfolios and new product development projects. They provided a starting point for further evaluation of product fit, partnership models and market-specific requirements.

Connecting Research with Manufacturing

Runda Rongjia’s development capabilities bring together application research, basic biological research, raw-material screening, pilot production and industrial manufacturing. Application research focuses on extraction, purification, stabilization and functional evaluation, while basic research uses multi-omics approaches to investigate vesicle composition and biological mechanisms.

Together, these capabilities support the development of cosmetic ingredients and finished products, with an emphasis on product characterization, quality assessment and scalable production. The ExoAion portfolio applies this approach across facial skincare and scalp care.

Advancing International Partnerships

Following CoCreate 2026, Runda Rongjia is continuing discussions with prospective partners on product development, private-label projects and distribution. The event created opportunities to understand buyer requirements and explore how ExoAion’s ingredient technology and finished products could fit different markets and business models.

Looking ahead, the company will continue connecting exosome research, application development and industrial manufacturing to advance the commercialization of natural-origin vesicle technology in the global beauty and personal care industry.

About Runda Rongjia BioTech

Shanghai Runda Rongjia Biological Technology Co., Ltd. is a biotechnology company focused on exosome research, application development and industrial production. Through its ExoAion brand, the company develops natural-origin skincare and scalp care products and supports beauty brands and distribution partners through ingredient supply, OEM and ODM collaboration.